MPS North America LLC Acquires Unbound Medicine, Inc.
Filing Summary
MPS North America LLC, a wholly-owned subsidiary of MPS Limited, has acquired a 100% stake in Unbound Medicine, Inc., a healthcare technology company based in the United States. The acquisition aligns with MPS Limited’s strategy to expand into the healthcare and medical information technology sector. Unbound Medicine provides digital medical reference and clinical decision-support solutions through subscription-based platforms. This acquisition is part of MPS Limited’s long-term growth strategy to enhance its digital content and technology-enabled services, focusing on the North American market.
MPS North America LLC, a wholly-owned subsidiary of MPS Limited, has announced the acquisition of a 100% stake in Unbound Medicine, Inc., a healthcare technology company based in the United States. The acquisition is subject to the terms and conditions outlined in the Stock Purchase Agreement and other definitive transaction documents. Unbound Medicine specializes in digital medical reference, clinical decision-support, and healthcare learning solutions.
The financial terms of the acquisition have not been disclosed in the filing. The transaction is structured to align with MPS Limited’s strategy of building platform-led, recurring-revenue businesses. The acquisition is expected to complement MPS Limited’s existing capabilities in digital content, platform engineering, and technology-enabled knowledge services. The acquisition is also aimed at supporting long-term value creation through revenue diversification and cross-selling opportunities.
Unbound Medicine operates proprietary mobile-first and web-based platforms that deliver evidence-based medical content to healthcare professionals, academic institutions, and professional associations. The company follows a subscription-led institutional business model and has a significant presence across the United States and Canada. Unbound Medicine serves leading medical schools, hospital systems, and healthcare associations, providing digital medical reference and clinical decision-support solutions.
The acquisition marks a strategic milestone for MPS Limited, as it enters the healthcare and medical information technology segment. This sector is considered a high-growth and knowledge-intensive vertical adjacent to MPS Limited’s core strengths in digital publishing, learning platforms, and technology-enabled content solutions. The acquisition is aligned with MPS Limited’s long-term growth strategy, focusing on building platform-led, recurring-revenue businesses.
The transaction is expected to enhance MPS Limited’s presence in the North American market, which remains a key strategic geography for the company. The acquisition is part of MPS Limited’s broader strategy to expand its capabilities in digital content and technology-enabled services, focusing on the healthcare and medical information technology sector.
MPS Limited was established as a subsidiary of Macmillan Limited in 1970. The company is a premier learning and platform solutions provider operating at the intersection of content, technology, and artificial intelligence. MPS Limited focuses on integrating deep content expertise with advanced platform engineering and AI-driven capabilities to scale rapidly and deepen strategic partnerships. The company is currently focused on unlocking synergies across its diverse portfolio of acquisitions and achieving significant scale through a market-oriented strategy and an enhanced acquisition playbook.